PharPoint Research > Resources & Insights > Infectious Disease > Virtual trials, COVID-19, & the future

Virtual trials, COVID-19, and the future of the industry

Editors Note: This article was last updated on April 28th, 2021. To learn more about PharPoint’s virtual capabilities and our experienced leadership team, visit our leadership page and get in contact with a representative. We’d love to discuss how PharPoint can support your upcoming traditional, virtual, remote, or hybrid clinical trial!

As the FDA continues to develop evolving guidelines, our industry has experienced a sudden, paradigm shift towards hybrid and virtual trials, with telemedicine becoming the “norm” for patient interaction across a variety of therapeutic areas. PharPoint is a strong advocate of this approach as an option to incorporate efficiencies for select indications and is positioned to advise clients as the rest of our industry adapts to this change.

“Even after the COVID-19 pandemic has subsided, clinical trial participants may grow accustomed to virtual or home health visits, and be hesitant to participate in more traditional, often travel-heavy, study processes to which the industry is accustomed,” Julie Robey, former Director of Clinical Operations at PharPoint stated.

“PharPoint has anticipated this shift for some time and is ready to advise sponsors on how to navigate the evolving FDA regulations while effectively moving to remote monitoring, tele-visits, home health visits, ePRO, eCOA, and eSource. These approaches directly speak to PharPoint’s flexibility. We’re able to run virtual trials through our existing procedures while offering a consultative, team-building approach.”

About PharPoint Research, Inc.

PharPoint is an award-winning and client focused contract research organization (CRO) that supports biotech, pharmaceutical, and medical device companies of all sizes. PharPoint offers clinical operations, biostatistics, statistical programming, data management, and strategic clinical trial consulting services. With a 95% client retention rate and 900+ clinical trials supported since 2007, PharPoint is able to support sponsors as they consider implementing virtual, remote, and hybrid studies.

For more information about PharPoint’s capabilities, contact our team. We look forward to supporting you.